Last reviewed · How we verify
NCT05382403: NOVIC
Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage
NA trial testing Jada® System in Postpartum Hemorrhage in 424 participants. Currently enrolling.
31 August 2026
Quick facts
| Lead sponsor | Women and Infants Hospital of Rhode Island |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 424 |
| Start date | 23 October 2023 |
| Primary completion | 31 August 2026 |
| Estimated completion | 30 April 2027 |
| Sites | 2 locations across Ghana |
Drugs / interventions tested
- Jada® System
- Standard care — full drug profile →
Conditions studied
- Postpartum Hemorrhage — all drugs for Postpartum Hemorrhage →
- Maternal Death — all drugs for Maternal Death →
Sponsor
Women and Infants Hospital of Rhode Island
Who can join
Adults 18 to 44, female only, with Postpartum Hemorrhage or Maternal Death. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This will be the first, definitive, randomized control trial (N=424) to test the hypothesis that the Jada® System is effective, safe and cost-effective in treating PPH, compared to standard care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05382403
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Jada® System
Trials testing the same drug.
- NCT04995887 — RUBY Post-Market Registry on the Jada® System · completed
Other recruiting trials for Postpartum Hemorrhage
Currently open trials in the same condition.
- NCT07401160 — Umbilical Cord Drainage to Prevent Postpartum Hemorrhage · NA · recruiting
- NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
- NCT07279545 — The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding · NA · recruiting
- NCT07229573 — The Effectiveness of Serious Game-Based Training for Nursing Students in Postpartum Haemorrhage Management · NA · recruiting
- NCT07005349 — THUMB: Multi-centre Cluster Trial for Caesarean Section Haemorrhage · NA · recruiting
Other Women and Infants Hospital of Rhode Island trials
Trials by the same sponsor.
- NCT06930508 — Bringing Medicines for HIV Prevention to a Family Planning Clinic · NA · not yet recruiting
- NCT07437131 — Community-Partnered Doula Support for Neonatal Intensive Care Unit Families · NA · recruiting
- NCT07077707 — Prenatal Genetics Chatbot Trial: Prenatal GENEie · NA · not yet recruiting
- NCT07222852 — Cardiovascular Protection After Preeclampsia With Enalapril · Phase 3 · not yet recruiting
- NCT05861531 — Combined Oral Motor Stimulation and Language on Preterm Infant Feeding · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05382403 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Women and Infants Hospital of Rhode Island
- Last refreshed: 21 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05382403.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing